journal article·2004-10

Architecture control of three‐dimensional polymeric scaffolds for soft tissue engineering. I. Establishment and validation of numerical models

Yang Cao, Malcolm R. Davidson, Andrea J. O'Connor, Geoffrey W. Stevens, Justin J. Cooper‐White

Publisher page

Abstract

Abstract One of the most important functions of artificial three‐dimensional (3D) polymeric scaffolds is to serve as a physical support to provide tissues with an appropriate architecture for in vitro cell culture as well as in vivo tissue regeneration. The production of three‐dimensional (3D) polymeric scaffolds with tailored macroporous architecture is thus a crucial step in promoting controlled vascularization and tissue growth within host environments. In this study, 3D poly(lactic‐co‐glycolic acid) (PLGA) scaffolds were manufactured by a thermally induced phase‐separation (TIPS) technique. By controlling the quenching strategy, 3D interconnected PLGA scaffolds with tunable pore size and alignment were obtained and characterized with the use of scanning electron microscopy (SEM). A series of numerical heat‐transfer models were established in an effort to describe the cooling process within the PLGA freezing regime. Among them, a two‐dimensional (2D) solidification model has proved to be the most successful in describing the quenching of the polymer solution and has the potential to be used to infer the various 3D macroporous architectures created from different quenching conditions. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 71A: 81–89, 2004
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (23)

Show source-provided references
1. 10.1089/ten.1999.5.40710.1089/ten.1999.5.407 ↗
2. 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O ↗
3. 10.1016/S0142-9612(99)00238-010.1016/S0142-9612(99)00238-0 ↗
4. 10.1016/S0142-9612(02)00146-110.1016/S0142-9612(02)00146-1 ↗
5. 10.1002/bit.26042060610.1002/bit.260420606 ↗
6. 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G ↗
7. DinhTQ WolffRG BergEP;Medtronic Inc. (Minneapolis MN) assignee. Medical device for delivering a theraputic substance and method therefore. U.S. Patent No. 6 399 144;2002.
8. 10.1111/j.1749-6632.2001.tb03853.x10.1111/j.1749-6632.2001.tb03853.x ↗
9. CaoY Cooper‐WhiteJJ O'ConnorAJ StevensGW.3D Poly(lactic‐co‐glycolic acid) scaffolds for soft tissue engineering. In: Proceedings of 12th Annual Conference of Australian Society for Biomaterials; Canberra Australia;2002.
10. CaoY CrollTI O'ConnorAJ StevensGW Cooper‐WhiteJJ.Systematic selection of solvents for the fabrication of 3D combined micro‐ and macroporous poly(lactic‐co‐glycolic acid) scaffold for soft tissue engineering. Forthcoming.
11. Cao Y
12. Birmingham Polymers Inc.Available:http://www.birminghampolymers.com/
13. The international resource for the international temperature scale of 1990. Available:http://www.its‐90.com
14. Fletcher CAJ · 1999
15. 10.1021/ja01322a02010.1021/ja01322a020 ↗
16. Trivedi R · 1989 · 451
17. Kurz W · 1990 · 67
18. Jennings TA · 2002
19. 10.1557/PROC-398-8710.1557/PROC-398-87 ↗
20. 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L ↗
21. 10.1016/0032-3861(96)87287-910.1016/0032-3861(96)87287-9 ↗
22. Holman JP · 2002
23. CRC Press · 2003